Microsoft Announces Winners of the 2009 Pharmaceutical and Life …
The News Review:
- Microsoft Announces Winners of the 2009 Pharmaceutical and Life …
- Redesigned Corporate Identity and nowEDC Software Upgrade Reflect …
- Swiss CR moves into Indian clinical trials market
- Study: Tablet Form of Dewormer as Effective as Gel
Microsoft Announces Winners of the 2009 Pharmaceutical and Life …
PR Newswire (press release)
As a result the Data Intelligence SQL Server-based solution has enabled the staff to quickly respond to new business challenges and opportunities. In addition over 200 sales representatives now have immediate access to their sales performance by account. — Clinical Development: Harvard Clinical Research Institute The Harvard Clinical Research Institute advances research by facilitating more efficient collaboration between the industry and academia. A highly respected academic research organization (AR) the Harvard Clinical Research Institute needed to aggregate data from multiple sources into one to generate increased efficiency and productivity. The Harvard Clinical Research Institute will make more information available to study constituents and respond more capably to a growing number of research centers around the world. The Harvard Clinical Research Institute deployed TranSenda’s ffice-Smart Clinical Trial Manager (SCTM) in order to access critical operational data from disparate systems and multiple clinical trials and manage it into a single source. The deployment of SCTM with its native interoperability with the Microsoft ffice SharePoint System resulted in a streamlined processing of operational data management significantly reducing the amount of time and effort involved in each study.
Redesigned Corporate Identity and nowEDC Software Upgrade Reflect …
PR Newswire (press release)
“Not only do we have the flexibility to deliver both paper and EDC studies but we also possess the wisdom to recommend the best approach for their specific needs. Should those needs dictate that nowEDC is the best solution for them they’ll know that they’re getting a version that is fast easily deployed and user-friendly. The redevelopment of nowEDC aims to make it even easier for customers to use and even faster to get real-time data from their clinical research while the logo and messaging demonstrate that Datatrial is responsive to the ever-changing clinical research industry–and its ever-improving place within it. Combined these latest moves highlight the company’s dedication to serving its customers and partners with maximum efficiency and minimum stress. “In the current economic climate there is more pressure on clinical research companies to design studies that make sense from both time and budgetary standpoints” said Black. “Meeting those demands has been made easier by the fact that we choose the companies that have the same team-oriented approach as us–so each customer is our most important customer. And because we treat them as part of the team we are as invested as they are in their clinical trial.
Swiss CR moves into Indian clinical trials market
Pharmafocus
2 –> Switzerland-based contract research organisation PFC Pharma Focus has set up an Indian subsidiary with the help of Excel Life Sciences a US firm that specialises in running trials in India. PFC India will be based in New Delhi and offer clinical trial support services such as study planning monitoring audit and data management services to biopharmaceutical companies and other CRs. India is fast becoming a global hub for clinical research with the number of trials carried out each year growing by 50% a year according to PFC. That view ties in with a report published by RNCS earlier this year which found that at present around 2% of all clinical trials in the world are carried out in India. That proportion is expected to more than double to 5% by 2012. The rapid growth is expected occur on the back of India's huge pool of potential trial participants ease of recruitment and cost savings that could slash the cost of trials by 50-75% compared to the US or Europe. The new PFC India venture "combines the strengths of a long standing and successful European CR" with ELS' "local expertise" PFC and ELS said in a joint statement.
Related from Liquidityx: FREX-Dollar euro soar vs Swiss franc after SNB intervenes
Study: Tablet Form of Dewormer as Effective as Gel
TheHorse.com
“Taken together our data demonstrate that the tablet formula was at least as safe and efficacious as the gel formula (Equimax oral gel) in killing immature Strongylus spp. larvae and in reducing arterial lesions in the parasite-infected horses” the study authors said. Commenting on the study Craig Reinemeyer DVM PhD president of East Tennessee Clinical Research said “This study confirms that many anthelmintics are effective regardless of the form in which they are administered which contradicts the notion that dewormers work better when given by stomach tube. ” The study was sponsored by Virbac S. The tablets are commercially available in Europe. The study “Anthelmintic efficacies of a tablet formula of ivermectin-praziquantel on horses experimentally infected with three Strongylus species”.
Written by admin on June 22nd, 2009 with
no comments.
Read more articles on News.